Synapse

  • About
  • FAQ
  • Reports
  • Contact Us
  • Memorial Sloan Kettering Cancer Center

  • Works
  • Groups
  • People
  • Publications
  • Publishers
  • In Press
Advanced
Search Within

Lang Ngo

  • Home
  • Works
  • Groups
  1. "Dharmarao Thapi"
Formats
  1. Meeting Abstract (2)
Groups
  1. Adult Leukemia (2)
  2. Center for Hematologic Malignancies (2)
People
  1. Chang-Yun Gui (2)
  2. Dharmarao Thapi (2)
  3. Paul Marks (2)
  4. Richard Rifkind (2)
  5. Weisheng Xu (2)
  6. Gisela Venta-Perez (1)
  1. Chang-Yun Gui (2)
  2. Dharmarao Thapi (2)
  3. Paul Marks (2)
  4. Richard Rifkind (2)
  5. Weisheng Xu (2)
  6. Gisela Venta-Perez (1)
  7. Victoria Richon (1)

More People

Fewer People

Years
  1. 2004 (2)
Publications
  1. Cancer Research (2)
Publishers
  1. American Association for Cancer Research (2)

Results (2)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Induction of mitotic defect is a novel anti-tumor mechanism of histone deacetylase inhibitor suberoylanilide hydroxamic acid
    Meeting Abstract

    Xu, W.; Perez, G.; Gui, C.; Thapi, D.; Ngo, L.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitor activation of p21 involves changes in promoter associated proteins, including HDAC1
    Meeting Abstract

    Gui, C.; Ngo, L.; Xu, W.; Thapi, D.; Perez, G. V.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Follow Us on
    Memorial Sloan Kettering Cancer Center | Memorial Hospital for Cancer and Allied Diseases | Sloan Kettering Institute
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences Patients & Caregivers

    Legal Disclaimer | Giving to the Library
    © 2022 Memorial Sloan Kettering Cancer Center Library